DIPRIVAN | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

DIPRIVAN
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

ASolution Propofol

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

Naprod Propofol

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

DIPRIVAN

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 12 USDMF, 11 CEP/COS, 5 JDMF, 4 EU WC, 7 KDMF, 4 NDC API, 2 VMF, 19 Listed Suppliers, $ API Reference Price

31 API Suppliers
12 USDMF
11 CEP/COS
5 JDMF
4 EU WC
7 KDMF
4 NDC API
2 VMF
19 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

136 FDF Dossiers, 15 FDA Orange Book, 66 Europe, 6 Canada, 19 South Africa, 30 Listed Dossiers

136 FDF Dossiers
15 FDA Orange Book
66 Europe
6 Canada
19 South Africa
30 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Kewpie Corporation, 4 Nanjing Well Pharmaceutical, 3 Actylis, 1 Finar, 1 Kerry, 1 Pluviaendo

2 EUROAPI
2 Kewpie Corporation
4 Nanjing Well Pharmaceutical
3 Actylis
1 Finar
1 Kerry
1 Pluviaendo

EXCIPIENTS BY APPLICATIONS

8 Parenteral, 5 Topical, 4 Emulsifying Agents, 3 Solubilizers, 1 Coating Systems & Additives, 1 Controlled & Modified Release, 1 Fillers, Diluents & Binders, 1 Film Formers & Plasticizers

8 Parenteral
5 Topical
4 Emulsifying Agents
3 Solubilizers
1 Coating Systems & Additives
1 Controlled & Modified Release
1 Fillers, Diluents & Binders
1 Film Formers & Plasticizers

DIGITAL CONTENT

34 NEWS #PharmaBuzz

34 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

46 Finished Drug Prices

46 Finished Drug Prices

MARKET PLACE

20 APIs, 39 FDF Dossiers

20 APIs
39 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 1 Health Canada Patents

2 US Patents
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 5 USP, 6 Others

3 EDQM
5 USP
6 Others

$ API Ref.Price (USD/KG) : 313 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2FRESENIUS KABI USA

filter Patent Number Reset all filters

2 All

01 18476010

02 18476010*PED

filter API Patent Reset all filters

2 All

01 1Y

02 1Blank

filter FDF Patent Reset all filters

2 All

01 1Y

02 1Blank

filter Expiration Date Reset all filters

2 All

01 12024-12-01

02 12025-06-01

Bachem Propofol

Product Main Page

01

FRESENIUS KABI USA

PharmScience R&D

Not Confirmed

FRESENIUS KABI USA

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-12-01

US Patent Number : 8476010

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 19627

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-12-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

FRESENIUS KABI USA

PharmScience R&D

Not Confirmed

FRESENIUS KABI USA

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-06-01

US Patent Number : 8476010*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 19627

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-06-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!